Who owns ELIEM THERAPEUTICS INC?
- Ticker: CLYM
- CUSIP Number: 28658r106
Tip: Access positions for across all investors
Analyze quarterly positions in Eliem Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eliem Therapeutics stock
Who bought or sold ELIEM THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 11M | $77M | 0% | Mar 2026 |
|
| MPM Oncology Impact Management | 2.6M | $18M | -3% | Mar 2026 |
|
| Braidwell | 1.5M | $11M | 100% | Mar 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.3M | $9.1M | 36% | Mar 2026 |
|
| Millennium Management | 1.3M | $8.7M | 331% | Mar 2026 |
|
| Vanguard Capital Management | 1.2M | $8.1M | 100% | Mar 2026 |
|
| Kynam Capital Management | 1.0M | $6.9M | -2% | Mar 2026 |
|
| Marshall Wace | 773k | $5.3M | 154% | Mar 2026 |
|
| Affinity Asset Advisors | 700k | $4.8M | -46% | Mar 2026 |
|
| Silverarc Capital Management | 685k | $4.7M | 100% | Mar 2026 |
|
| Driehaus Capital Management | 601k | $4.1M | 0% | Mar 2026 |
|
| ADAR1 Capital Management | 598k | $4.1M | -58% | Mar 2026 |
|
| Susquehanna International | 459k | $3.1M | 3% | Mar 2026 |
|
| Nan Fung Trinity | 421k | $2.9M | -9% | Mar 2026 |
|
| Sphera Funds Management | 419k | $2.9M | -55% | Mar 2026 |
|
| BlackRock | 402k | $2.8M | 3% | Mar 2026 |
|
| Citadel Advisors | 346k | $2.4M | 45% | Mar 2026 |
|
| Geode Capital Management | 313k | $2.1M | 1% | Mar 2026 |
|
| Two Sigma Investments | 311k | $2.1M | -45% | Mar 2026 |
|
| Diadema Partners | 286k | $2.0M | 100% | Mar 2026 |
|
| TD Asset Management | 250k | $1.7M | 2% | Mar 2026 |
|
| Morgan Stanley | 234k | $1.6M | 58% | Mar 2026 |
|
| Longaeva Partners | 218k | $1.5M | 100% | Mar 2026 |
|
| Renaissance Technologies | 217k | $1.5M | -32% | Mar 2026 |
|
| Superstring Capital Management | 199k | $1.4M | 100% | Mar 2026 |
|
| Jane Street | 186k | $1.3M | -1% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 159k | $1.1M | 100% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 156k | $1.1M | 11% | Mar 2026 |
|
| Goldman Sachs Group | 150k | $1.0M | -33% | Mar 2026 |
|
| Verdad Advisers | 145k | $990k | 100% | Mar 2026 |
|
| Bridgeway Capital Management | 134k | $920k | -16% | Mar 2026 |
|
| State Street Corporation | 132k | $904k | 2% | Mar 2026 |
|
| Seven Fleet Capital Management | 131k | $895k | 71% | Mar 2026 |
|
| Northern Trust | 128k | $876k | 3% | Mar 2026 |
|
| Botty Investors | 121k | $832k | 0% | Mar 2026 |
|
| Peapod Lane Capital | 109k | $740k | -81% | Mar 2026 |
|
| Dimensional Fund Advisors | 104k | $715k | 100% | Mar 2026 |
|
| Qube Research & Technologies | 104k | $714k | 201% | Mar 2026 |
|
| Boothbay Fund Management | 92k | $632k | 100% | Mar 2026 |
|
| 683 Capital Management | 90k | $617k | -55% | Mar 2026 |
|
| UBS Group | 86k | $589k | 21% | Mar 2026 |
|
| Persistent Asset Partners | 72k | $495k | 684% | Mar 2026 |
|
| LPL Financial | 60k | $414k | -3% | Mar 2026 |
|
| Point72 Asset Management | 59k | $405k | -92% | Mar 2026 |
|
| Brevan Howard Capital Management | 57k | $388k | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 55k | $373k | 12% | Mar 2026 |
|
| Bank of America Corporation | 53k | $363k | 100% | Mar 2026 |
|
| XTX Topco | 52k | $356k | 49% | Mar 2026 |
|
| Barclays | 49k | $335k | -21% | Mar 2026 |
|
| Squarepoint Ops | 43k | $294k | 100% | Mar 2026 |
|
| Hrt Financial | 37k | $254k | 100% | Mar 2026 |
|
| Cantor Fitzgerald, L. P. | 30k | $206k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 29k | $200k | 5578% | Mar 2026 |
|
| Arrowpoint Investment Partners | 25k | $168k | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 22k | $151k | 100% | Mar 2026 |
|
| Fox Run Management | 19k | $126k | 100% | Mar 2026 |
|
| Raymond James Financial | 18k | $121k | 100% | Mar 2026 |
|
| OMERS Administration Corporation | 17k | $114k | -80% | Mar 2026 |
|
| William Blair $ Company | 12k | $82k | 9% | Mar 2026 |
|
| Diametric Capital | 11k | $77k | 100% | Mar 2026 |
|
| JustInvest | 11k | $77k | 1% | Mar 2026 |
|
| Susquehanna Portfolio Strategies | 11k | $76k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 10k | $69k | 100% | Mar 2026 |
|
| Balyasny Asset Management | 7.0k | $48k | -51% | Mar 2026 |
|
| FMR | 6.4k | $44k | 1% | Mar 2026 |
|
| Tower Research Capital | 5.8k | $40k | 74% | Mar 2026 |
|
| Citigroup | 5.8k | $40k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 3.4k | $23k | 467% | Mar 2026 |
|
| Advisory Services Network | 2.0k | $14k | 100% | Mar 2026 |
|
| NISA Investment Advisors | 573.00 | $3.9k | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 266.00 | $1.9k | 100% | Mar 2026 |
|
| Fortitude Family Office | 92.00 | $629.997600 | 100% | Mar 2026 |
|
| Russell Investments | 79.00 | $540.999900 | 100% | Mar 2026 |
|
| Royal Bank of Canada | 79.00 | $0 | 100% | Mar 2026 |
|
| SRS Capital Advisors | 51.00 | $110.001900 | 100% | Mar 2026 |
|
| Hanson McClain Advisors | 45.00 | $309.001500 | 100% | Mar 2026 |
|
| CWM | 18.00 | $122.999400 | -38% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 1.00 | $7.000000 | 0% | Mar 2026 |
|
Who sold out of Eliem Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ameriprise Financial | Dec 2025 | 140k | $558k |
| Two Sigma Advisers | Dec 2025 | 125k | $499k |
| Citizens Financial Group | Dec 2025 | 28k | $113k |
| Hsbc Holdings | Dec 2025 | 25k | $99k |
| Springbok Capital Management | Dec 2025 | 20k | $80k |
| Chicago Partners Investment | Dec 2025 | 11k | $55k |
| Virtu Financial | Dec 2025 | 11k | $43k |
| Scientech Research | Dec 2025 | 10k | $42k |
| Harbour Investments | Dec 2025 | 2.0k | $8.0k |